METASTATIC NEUROENDOCRINE TUMORS

Clinical trials for METASTATIC NEUROENDOCRINE TUMORS explained in plain language.

Never miss a new study

Get alerted when new METASTATIC NEUROENDOCRINE TUMORS trials appear

Sign up with your email to follow new studies for METASTATIC NEUROENDOCRINE TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New 'Smarter' radiation therapy tested for Tough-to-Treat cancers

Disease control Recruiting now

This study is testing a new radioactive drug called Terbium-161 DOTATATE for people with advanced neuroendocrine tumors that have spread and have stopped responding to the current standard radiation therapy. The goal is to see if this new drug is safe and can better control the c…

Matched conditions: METASTATIC NEUROENDOCRINE TUMORS

Phase: PHASE2 • Sponsor: Tata Memorial Hospital • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

METASTATIC NEUROENDOCRINE TUMORS

Get alerted when new METASTATIC NEUROENDOCRINE TUMORS trials appear

New 'Smarter' radiation therapy tested for Tough-to-Treat cancers